BridgeBio Oncology Therapeutics, Inc. (BBOT)

Every official BridgeBio Oncology Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

BridgeBio Oncology Therapeutics, Inc. documents

• BridgeBio Oncology Therapeutics, Inc. 10-K 2026BBOT 10-K 2026: annual report for fiscal 2026
• BridgeBio Oncology Therapeutics, Inc. 10-K 2025BBOT 10-K 2025: annual report for fiscal 2025
• BridgeBio Oncology Therapeutics, Inc. 10-K 2024BBOT 10-K 2024: annual report for fiscal 2024
• BridgeBio Oncology Therapeutics, Inc. 10-K 2023BBOT 10-K 2023: annual report for fiscal 2023
• BridgeBio Oncology Therapeutics, Inc. 10-K 2022BBOT 10-K 2022: annual report for fiscal 2022
• BridgeBio Oncology Therapeutics, Inc. 10-Q 2026BBOT 10-Q 2026: quarterly report for fiscal 2026
• BridgeBio Oncology Therapeutics, Inc. 10-Q 2025BBOT 10-Q 2025: quarterly report for fiscal 2025
• BridgeBio Oncology Therapeutics, Inc. 10-Q 2024BBOT 10-Q 2024: quarterly report for fiscal 2024
• BridgeBio Oncology Therapeutics, Inc. 10-Q 2023BBOT 10-Q 2023: quarterly report for fiscal 2023
• BridgeBio Oncology Therapeutics, Inc. 10-Q 2022BBOT 10-Q 2022: quarterly report for fiscal 2022
• BridgeBio Oncology Therapeutics, Inc. 8-K 2026BBOT 8-K 2026: current report for fiscal 2026
• BridgeBio Oncology Therapeutics, Inc. 8-K 2025BBOT 8-K 2025: current report for fiscal 2025
• BridgeBio Oncology Therapeutics, Inc. 8-K 2024BBOT 8-K 2024: current report for fiscal 2024
• BridgeBio Oncology Therapeutics, Inc. 8-K 2023BBOT 8-K 2023: current report for fiscal 2023
• BridgeBio Oncology Therapeutics, Inc. 8-K 2022BBOT 8-K 2022: current report for fiscal 2022
• BridgeBio Oncology Therapeutics, Inc. DEF 14A 2026BBOT DEF 14A 2026: proxy statement for fiscal 2026
• BridgeBio Oncology Therapeutics, Inc. DEF 14A 2025BBOT DEF 14A 2025: proxy statement for fiscal 2025
• BridgeBio Oncology Therapeutics, Inc. DEF 14A 2024BBOT DEF 14A 2024: proxy statement for fiscal 2024
• BridgeBio Oncology Therapeutics, Inc. DEF 14A 2023BBOT DEF 14A 2023: proxy statement for fiscal 2023
• BridgeBio Oncology Therapeutics, Inc. DEF 14A 2022BBOT DEF 14A 2022: proxy statement for fiscal 2022
• BridgeBio Oncology Therapeutics, Inc. Form 4 2026BBOT Form 4 2026: insider trading filing for fiscal 2026
• BridgeBio Oncology Therapeutics, Inc. Form 4 2025BBOT Form 4 2025: insider trading filing for fiscal 2025
• BridgeBio Oncology Therapeutics, Inc. Form 4 2024BBOT Form 4 2024: insider trading filing for fiscal 2024
• BridgeBio Oncology Therapeutics, Inc. Form 4 2023BBOT Form 4 2023: insider trading filing for fiscal 2023
• BridgeBio Oncology Therapeutics, Inc. Form 4 2022BBOT Form 4 2022: insider trading filing for fiscal 2022
• BridgeBio Oncology Therapeutics, Inc. S-1 2026BBOT S-1 2026: registration statement for fiscal 2026
• BridgeBio Oncology Therapeutics, Inc. S-1 2025BBOT S-1 2025: registration statement for fiscal 2025
• BridgeBio Oncology Therapeutics, Inc. S-1 2024BBOT S-1 2024: registration statement for fiscal 2024
• BridgeBio Oncology Therapeutics, Inc. S-1 2023BBOT S-1 2023: registration statement for fiscal 2023
• BridgeBio Oncology Therapeutics, Inc. S-1 2022BBOT S-1 2022: registration statement for fiscal 2022
• BridgeBio Oncology Therapeutics, Inc. 13F 2026BBOT 13F 2026: institutional holdings for fiscal 2026
• BridgeBio Oncology Therapeutics, Inc. 13F 2025BBOT 13F 2025: institutional holdings for fiscal 2025
• BridgeBio Oncology Therapeutics, Inc. 13F 2024BBOT 13F 2024: institutional holdings for fiscal 2024
• BridgeBio Oncology Therapeutics, Inc. 13F 2023BBOT 13F 2023: institutional holdings for fiscal 2023
• BridgeBio Oncology Therapeutics, Inc. 13F 2022BBOT 13F 2022: institutional holdings for fiscal 2022

More companies